World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
8655
World Ranking
14090
National Ranking
418

Stefano Pepe publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Stefano Pepe sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 185 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Stefano Pepe D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Stefano Pepe sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Stefano Pepe is affiliated with the University of Salerno in Italy and has conducted extensive research primarily within the field of medicine. Their work spans multiple subfields, including oncology, pulmonary and respiratory medicine, immunology, molecular biology, and computer networks and communications.

The research topics covered by Stefano Pepe are diverse, with a particular emphasis on cancer immunotherapy and biomarkers. Key focus areas include CAR-T cell therapy research, lung cancer treatments and mutations, lung cancer research studies, immunotherapy and immune responses, brain metastases and treatment, and phagocytosis and immune regulation.

Stefano Pepe's recent publications demonstrate a focus on checkpoint-based immunotherapy and cancer treatment mechanisms. Notable recent papers include:

  • "Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients" (2020), published in International Journal of Molecular Sciences
  • "Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC" (2020), published in Frontiers in Immunology
  • "Immune checkpoint inhibitors for the treatment of melanoma" (2022), published in Expert Opinion on Biological Therapy
  • "Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors" (2021), published in Journal of Medicinal Chemistry
  • "Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists" (2020), published in Journal for ImmunoTherapy of Cancer

The frequent co-authors collaborating with Stefano Pepe include Francesco Sabbatino, Giovanna Polcaro, Luigi Liguori, Angelo Luciano, and Jessica Dal Col. The number of collaborations varies, with the highest count of joint publications being with Francesco Sabbatino.

Stefano Pepe's research has been published in several journals with multiple contributions to notable venues such as Frontiers in Immunology, Preprints.org, International Journal of Molecular Sciences, Expert Opinion on Biological Therapy, and Journal of Medicinal Chemistry.

Best Publications

  • Antitumor Activity of Sequential Treatment with Topotecan and Anti-Epidermal Growth Factor Receptor Monoclonal Antibody C225

    Fortunato Ciardiello;Roberto Bianco;Vincenzo Damiano;Sonya De Lorenzo

  • The Multiple Sulfatase Deficiency Gene Encodes an Essential and Limiting Factor for the Activity of Sulfatases

    Maria Pia Cosma;Stefano Pepe;Ida Annunziata;Robert F Newbold

  • A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

    F De Vita;M Orditura;E Matano;R Bianco

  • Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)

    Cataldo Bianco;Giampaolo Tortora;Roberto Bianco;Roberta Caputo

  • BRAF is a therapeutic target in aggressive thyroid carcinoma.

    Giuliana Salvatore;Valentina De Falco;Paolo Salerno;Tito Claudio Nappi

  • p53 Alterations in Non-Small Cell Lung Cancers Correlate with Metastatic Involvement of Hilar and Mediastinal Lymph Nodes

    Marchetti A;Buttitta F;Merlo G;Diella F

  • cAMP-dependent protein kinase: role in normal and malignant growth

    Yoon S. Cho-Chung;Stefano Pepe;Timothy Clair;AlfreD.O. Budillon

  • A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

    Giuseppina Della Vittoria Scarpati;Francesca Falcetta;Chiara Carlomagno;Paolo Ubezio

  • Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.

    Sabino De Placido;Michelino De Laurentiis;Chiara Carlomagno;Ciro Gallo

  • Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion.

    Frederic Lluis;Elisa Pedone;Stefano Pepe;Maria Pia Cosma

  • Epidermal Growth Factor Receptor (EGFr) Expression in Non-small Cell Lung Carcinomas Correlates with Metastatic Involvement of Hilar and Mediastinal Lymph Nodes in the Squamous Subtype

    G. Fontanini;S. Vignati;D. Bigini;A. Mussi

  • Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells

    Elena Di Gennaro;Marcella Barbarino;Francesca Bruzzese;Sonya De Lorenzo

  • Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors

    M. P. Morelli;T. Cascone;T. Troiani;T. Troiani;F. De Vita

  • Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells.

    A. Leardi;M. Caraglia;Carmine Selleri;Stefano Pepe

  • Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications

    Francesco Perri;Roberto Pacelli;Giuseppina Della Vittoria Scarpati;Laura Cella

  • Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase.

    Giampaolo Tortora;Hiroshi Yokozaki;Stefano Pepe;Timothy Clair

  • Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery

    Monica Cardone;Vinicia Assunta Polito;Stefano Pepe;Linda Mann

  • The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.

    Gabriella Fontanini;Paolo Macchiarini;Stefano Pepe;Angela Ruggievo

  • Cooperative Inhibition of Renal Cancer Growth by Anti-Epidermal Growth Factor Receptor Antibody and Protein Kinase A Antisense Oligonucleotide

    Fortunato Ciardiello;Rosa Caputo;Roberto Bianco;Vincenzo Damiano

  • Ipilimumab in the treatment of metastatic melanoma: management of adverse events

    Giuseppina Della Vittoria Scarpati;Celeste Fusciello;Francesco Perri;Francesco Sabbatino

Frequent Co-Authors

Fortunato Ciardiello
Fortunato Ciardiello University of Campania "Luigi Vanvitelli"
Giampaolo Tortora
Giampaolo Tortora University of Verona
Michele Caraglia
Michele Caraglia University of Campania "Luigi Vanvitelli"
Sabino De Placido
Sabino De Placido University of Naples Federico II
Alfredo Budillon
Alfredo Budillon Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Yoon S. Cho-Chung
Yoon S. Cho-Chung National Institutes of Health
Soldano Ferrone
Soldano Ferrone Harvard University
Andrea Ballabio
Andrea Ballabio Baylor College of Medicine
Nicola Normanno
Nicola Normanno Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Alberto Abbruzzese
Alberto Abbruzzese University of Campania "Luigi Vanvitelli"

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in broadening your career options after studying Biology or Biochemistry in the USA, there are several flexible online degree pathways to consider. For example, pursuing an online nutritionist degree allows graduates to specialize in food sciences and dietetics, fields closely linked to biochemistry.

For those looking toward healthcare leadership, accredited distance programs like online mha programs cahme accredited can prepare you for management roles in hospitals and clinics. If advancing to a clinical doctorate is your goal, there are dnp program without clinical hours options, which can be ideal for those seeking flexibility or already working in healthcare.

Online advanced degrees in management—like a doctorate in healthcare administration online—are also in demand for biochemistry or biology graduates wishing to move into high-level administrative roles. These programs offer the convenience of online learning while expanding your qualifications and career potential in the evolving healthcare sector.

Best Scientists Citing Stefano Pepe

Trending Scientists